Parameter
| Biomarker | GPC1⁺ exosomes | Full name | Glypican-1 positive exosomes | Molecular Type | Protein (secrete related) |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Early diagnosis and prognosis evaluation | ||
| Disease | Pancreatic Cancer | Disease Subtypes | / | ||
| Organ | Pancreas | Test Sample / Technology Platform | Serum (outside secrete separation flow cytometry) + | ||
| Pathobiological Mechanisms | Outside GPC1 body surface protein secretion, and by the PDAC cells secrete, participate in tumor microenvironment niche form before regulation and distant metastasis | ||||
| Clinical Availability Status | Clinical research phase: diagnostic sensitivity and specificity are close to 100%, which has been verified in large-scale samples | ||||
| Notes and Dynamics | Can distinguish between PDAC and chronic pancreatitis and healthy people, is independent of disease specific prognostic markers, and prognostic value is better than that of CA19-9 | ||||